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Background: The SenseWear Armband (SWA) provides simple and non-invasive measures of energy expenditure (EE) during physical activity,
however its accuracy in adults with cystic ﬁbrosis (CF) during free living physical activities has not been established.
Methods: 26 CF adults (mean FEV1 63% predicted; 11 males) completed a series of standardised static and active tasks with simultaneous analysis
of EE via the SWA and indirect calorimetry (IC).
Results:Mean difference and limits of agreement between EE values from the SWA and IC across all activities were −0.02 METs (95% CI −1.1 to
1.1). There was moderate agreement between the two measures (ICC 0.4; 95% CI: 0 to 0.7; p = 0.03). For individual activity tasks ICC ranged
from 0.1 to 0.6.
Conclusion: Overall, the SWA demonstrated good agreement with IC for EE estimates in CF adults during a series of free-living activities,
however accuracy was variable when assessing EE for speciﬁc activities of shorter duration.
© 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Activity monitor; Accelerometer; Free-living; Physical activity; Energy expenditure1. Introduction
Regular participation in physical activity and exercise is
considered important for individuals with cystic fibrosis (CF) [1].
Lower physical activity levels have been associated with more☆ Data from this manuscript was presented in poster form at the 10th Australasian
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http://dx.doi.org/10.1016/j.jcf.2013.11.008rapid decline in FEV1 in girls with CF [2], and with morbidity and
mortality in other respiratory diseases [3–5]. Accurate quantifica-
tion of physical activity participation, in terms of frequency,
intensity and duration, may therefore be important for optimal
management in this group.
The most accurate measures of energy expenditure (EE) during
daily activity are doubly labelled water and indirect calorimetry
(IC) [6]. These assessments are cumbersome, expensive or unable
to provide information on activity pattern and intensity [7].
The SenseWear Pro3 Armband (SWA) (BodyMedia, Pittsburgh,
Pennsylvania, USA) is an accelerometer with physiological
sensors, previously used to estimate EE and patterns of physicalby Elsevier B.V. All rights reserved.
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chronic disease [8,12,13]. However, differences in the nature of
physical activity participation undertaken relative to age, and
elevated EE both at rest and during activity in people with CF
[9,10], may hamper the ability to extrapolate SWA EE estimations
obtained from people with COPD or healthy controls respectively.
We aimed to determine the accuracy of the SWA in estimating EE
during free-living activities in adults with CF.2. Methods
Adults with stable CF aged greater than 18 years were
eligible to participate. Potential participants were excluded if
they had co-morbidities that limited physical activity partici-
pation; were requiring intravenous antibiotics or long-term
oxygen therapy; were pregnant; or had received a lung
transplant. Ethical approval for this study was obtained from
the appropriate committees and written, informed consent
obtained from each participant.2.1. Protocol
Participants completed a series of seven physical activity tasks
with simultaneous assessment of EE using the SWA and IC
(MetaMax 3B, Cortex; Leipzig, Germany) in an indoor environ-
ment over≥1 h. Static tasks comprised supine lying, unsupported
sitting and upright standing. Active tasks were stationary cycling,
walking (6-minute walk test (6MWT)), a functional upper-limb
test (the Grocery Shelving Task (GST) [14]) and stair-climbing.
Participants cycled at a perceived intensity of 11–13 on the Borg
rating of perceived exertion (RPE) scale, corresponding to
moderate intensity [15]. The 6MWT and GST were performed
according to standard protocols [14,16]. Participants undertook
stair-climbing in an indoor stairwell (24 steps), and were instructed
to descend and ascend the stairs as they would in everyday life.
Excluding the GST and stair-climbing all tasks were 6-min in
duration.Table 1
Participant characteristics (n = 26; 11 males; 1 left hand dominant).
Characteristic Mean (SD)
Age, years 28 (7)
FEV1% predicted 63 (25)
Height, cm 168 (8)
BMI, kg/m2 22 (2)
Cystic fibrosis related diabetes (n) 8
Pancreatic insufficient (n) 26
Results are presented as mean (SD) unless otherwise stated; FEV1 = forced
expiratory volume in 1 s; BMI = body mass index; n = number.2.2. Measurement of energy expenditure
The SWA is a portable, multi-sensor armband that contains a
bi-axial accelerometer and sensors that measure galvanic skin
response, heat flux and skin temperature. The SWA (Pro3 model)
is worn on the right upper arm. Estimates of EE were generated by
the proprietary algorithm (Version 6.1) for each minute of wear.
Measurement of exhaled respiratory gases was performed using
indirect calorimetry (IC) via the MetaMax 3B (Cortex; Leipzig,
Germany). The MetaMax 3B is a portable system consisting of a
facemask with a turbine flow-meter, tubing, battery pack and
transmitting unit which are lightweight (570 g) and attach to the
participant via a chest harness. Data were recorded via telemetry
and downloaded to a computer for analysis. Device calibration
according to manufacturer instructions was undertaken prior to
each use.2.3. Analyses
Statistical analyses were conducted using PASW (Version
18). Extent of agreement and bias in EE estimates between
devices were assessed using intra-class correlation coefficients
(ICCs) (ICC 2,1) and Bland–Altman analyses respectively.
Data are expressed as mean ± standard deviation (SD) and 95%
confidence intervals (95% CI) unless otherwise stated. Energy
expenditure, expressed in metabolic equivalents (METs), was
averaged for the final 3-min of the activity task for the three
static activities and for cycling and walking. For the GST and
stair-climbing the average EE for 1-min from the commence-
ment of the activity was analysed.
Sample size was calculated based on the level of agreement
between the two measures. An ICC greater than 0.4 would detect
at least a moderate relationship between EE estimates from the
SWA and IC [17]. To achieve 80% power at a 0.05 level test to
reject the null hypothesis that the ICC is less than or equal to 0.4
(≤0.4) 20–30 participants would be required [18].
3. Results
Twenty-six adults (11 males) with stable CF, mean (SD) age
28 [7] years and mean forced expiratory volume in 1 s (FEV1)
63% predicted (range 29 to 108%) were recruited (see Table 1).
Twenty-three participants completed all seven physical activity
tasks. Three participants failed to complete all tasks, two due to
time constraints, and one due to equipment difficulties.
Energy expenditure from the SWA, for all tasks combined,
demonstrated a moderate degree of agreement with EE
measures obtained via IC (ICC 0.4; 95% CI: 0 to 0.7). The
Bland–Altman plot is shown in Fig. 1. The mean difference
between the two devices was −0.02 METs (limits of agreement
(LOA) 1.1 to−1.1 METs). A similar result was achievedwhen EE
estimates for the 23 participants who completed all tasks were
analysed (mean difference 0.01 METs; LOA −1 to 1 METs).
When tasks were analysed individually the ICCs ranged
from 0.1 to 0.6 (Table 2). The range of ICCs was not different
between static and active tasks. The individual tasks of supine
lying and stair-climbing were the only tasks to show poor
agreement between EE estimates from the SWA and IC, and
did not achieve statistical significance (ICC 0.3; 95% CI: −0.1
to 0.6 and ICC 0.1; 95% CI −0.5 to 0.3, respectively). All other
tasks showed significant agreement between devices for
measures of EE.
Fig. 1. Bland–Altman plot for agreement between energy expenditure (EE (METs)) estimated by the SenseWear Pro3 Armband (SWA) and indirect calorimetry (IC)
for all tasks combined. Legend: EE = energy expenditure; IC = indirect calorimetry; SWA = SenseWear Armband; METs = metabolic equivalents. Solid line
represents mean difference between testing occasions; Dashed line = limits of agreement.
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This study evaluated the agreement between EE measures
estimated by a physiological activity monitor, the SWA, and IC
during a series of free-living activities in adults with CF. The
small difference in EE measures between devices is comparable
with the relationship between SWA and IC estimates of EE
during free-living activity in people with COPD [8]. Likewise,
the limits of agreement established in this study of adults with CF
are similar to those reported in healthy adults (±1.4 METs) [6]Table 2
Comparison of energy expenditure from SenseWear Pro3 Armband™ using
commercially available algorithm and indirect calorimetry during a series of
free-living activities (mean (SD)).









Supine lying (n = 26) 1.2 (0.3) 1.6 (0.3) 0.3 −0.1 to 0.6
Sitting (n = 26) 1.3 (0.4) 1.5 (0.3) 0.6 0.3 to 0.8
Upright standing (n = 25) 1.6 (0.7) 1.6 (0.3) 0.4 0.0 to 0.7
Cycling (n = 25) 3.8 (1.4) 4.7 (1.4) 0.5 0.1 to 0.7
Walking (n = 25) 4.8 (0.8) 3.7 (0.9) 0.6 0.2 to 0.8
GST (n = 24) 2.5 (1.0) 2.1 (0.5) 0.4 0.0 to 0.7
Stair-climbing (n = 23) 2.8 (1.1) 2.8 (0.7) 0.1 −0.5 to 0.3
All activities (n = 26) 2.6 (1.4) 2.6 (1.2) 0.4 0.0 to 0.7
SWA = SenseWear Armband; IC—indirect calorimetry; METs = metabolic
equivalents; SD = standard deviation; ICC = intraclass correlation coefficient;
95% CI = 95% confidence interval; GST = Grocery Shelving Task.and people with COPD during free-living activities (±1.3 METs)
[8]. This would suggest that despite variations in motor patterns
relative to age, and higher EE at rest and during activity in people
with CF, the SWA functions similarly to in other populations
when estimating EE.
In adults with CF assessed during treadmill walking, limits
of agreement between the SWA and IC were ±3.3 METs [19].
This variation in reported limits of agreement between the CF
studies may reflect the activities assessed, with the present
study combining lifestyle and moderate intensity activities as
compared to treadmill walking only. The hypersalinity of sweat
in people with CF has previously been found not to impair
SWA function [19] and this finding, in addition to our data, can
increase our confidence in estimates of EE from the SWA
during daily activities. We did not assess higher intensity
activities such as running, weight training or sports related
skills which may be undertaken by adults with CF. However,
given that the function of the SWA in CF appears comparable
to other populations, it seems likely that the SWA could
adequately assess EE during these activities.
In conclusion, the SWA demonstrated good agreement with
IC for physical activity intensity in adults with CF during a
combined series of free-living activities, but was more variable
in assessing EE for specific activity tasks.Funding
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